James Richard Reis insider trades: Arcadia Biosciences (RKDA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 20, 2015 | RKDA | ↑ Buy | 12,500 | $8.00 | $100K | Direct | May 22, 2015 (2d) |
| Jan 13, 2009 | APOL | ↓ Sell | 2,500 | $83.00 | $208K | Direct | Jan 14, 2009 (1d) |
| Apr 3, 2008 | APOL | ↑ Buy | 2,000 | $44.23 | $88K | Direct | Apr 4, 2008 (1d) |
| Sep 19, 2005 | GAN | ↑ Buy | 15,800 | $1.71 | $27K | Direct | Sep 20, 2005 (1d) |
| Jun 29, 2005 | GNAC | ↑ Buy | 10,000 | $1.59 | $16K | Direct | Jul 1, 2005 (2d) |
| Jun 28, 2005 | GNAC | ↑ Buy | 42,000 | $1.57 | $66K | Direct | Jun 29, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About James Richard Reis's insider trades
James Richard Reis is a director at Arcadia Biosciences (RKDA). Since Jun 28, 2005, James has reported 5 open-market purchases worth $297K and 1 sale worth $208K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (5 filings), option exercises (4 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RKDA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.